148 related articles for article (PubMed ID: 8794338)
1. Selective transmission of human immunodeficiency virus type 1 variants to SCID mice reconstituted with human peripheral blood monoclonal cells.
Markham RB; Schwartz DH; Templeton A; Margolick JB; Farzadegan H; Vlahov D; Yu XF
J Virol; 1996 Oct; 70(10):6947-54. PubMed ID: 8794338
[TBL] [Abstract][Full Text] [Related]
2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
[TBL] [Abstract][Full Text] [Related]
3. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S
J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
[TBL] [Abstract][Full Text] [Related]
5. Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides.
Di Fabio S; Giannini G; Lapenta C; Spada M; Binelli A; Germinario E; Sestili P; Belardelli F; Proietti E; Vella S
AIDS; 2001 Nov; 15(17):2231-8. PubMed ID: 11698695
[TBL] [Abstract][Full Text] [Related]
6. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
[TBL] [Abstract][Full Text] [Related]
7. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.
Scoggins RM; Taylor JR; Patrie J; van't Wout AB; Schuitemaker H; Camerini D
J Virol; 2000 Apr; 74(7):3205-16. PubMed ID: 10708437
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 pathogenesis in SCID-hu mice correlates with syncytium-inducing phenotype and viral replication.
Camerini D; Su HP; Gamez-Torre G; Johnson ML; Zack JA; Chen IS
J Virol; 2000 Apr; 74(7):3196-204. PubMed ID: 10708436
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 populations in blood and semen.
Delwart EL; Mullins JI; Gupta P; Learn GH; Holodniy M; Katzenstein D; Walker BD; Singh MK
J Virol; 1998 Jan; 72(1):617-23. PubMed ID: 9420266
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID mice.
Koup RA; Hesselton RM; Safrit JT; Somasundaran M; Sullivan JL
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):279-84. PubMed ID: 8018388
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
Okuma K; Tanaka R; Ogura T; Ito M; Kumakura S; Yanaka M; Nishizawa M; Sugiura W; Yamamoto N; Tanaka Y
J Infect Dis; 2008 Jan; 197(1):134-41. PubMed ID: 18171296
[TBL] [Abstract][Full Text] [Related]
14. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice.
Lapenta C; Spada M; Santini SM; Racca S; Dorigatti F; Poli G; Belardelli F; Alfano M
Int Immunol; 2005 Apr; 17(4):469-75. PubMed ID: 15746245
[TBL] [Abstract][Full Text] [Related]
15. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
[TBL] [Abstract][Full Text] [Related]
16. hu-PBL-SCID mice can be protected from HIV-1 infection by passive transfer of monoclonal antibody to the principal neutralizing determinant of envelope gp120.
Safrit JT; Fung MS; Andrews CA; Braun DG; Sun WN; Chang TW; Koup RA
AIDS; 1993 Jan; 7(1):15-21. PubMed ID: 7680205
[TBL] [Abstract][Full Text] [Related]
17. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture.
Schuitemaker H; Kootstra NA; de Goede RE; de Wolf F; Miedema F; Tersmette M
J Virol; 1991 Jan; 65(1):356-63. PubMed ID: 1985204
[TBL] [Abstract][Full Text] [Related]
18. The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes.
Picchio GR; Gulizia RJ; Wehrly K; Chesebro B; Mosier DE
J Virol; 1998 Mar; 72(3):2002-9. PubMed ID: 9499054
[TBL] [Abstract][Full Text] [Related]
19. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192
[TBL] [Abstract][Full Text] [Related]
20. Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
Yoshida A; Tanaka R; Murakami T; Takahashi Y; Koyanagi Y; Nakamura M; Ito M; Yamamoto N; Tanaka Y
J Virol; 2003 Aug; 77(16):8719-28. PubMed ID: 12885891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
